The Clinical Observationg on HAM for Acute Myeloid Leukemia
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 250
- 试验地点
- 1
- 主要终点
- patient survival time
研究概览
简要总结
By observation of the inpatients in shenzhen people's hospital,research the curative effect of the two chemotherapy schemes on AML-High dose of cytarabine and HAM.
详细描述
The patients of AML in shenzhen people's hospital were randomly divided into two therapy groups.One group was treated by High dose of cytarabine ,and the other was HAM.Evaluate the two chemotherapy schemes by bone marrow suppression time and patient survival time.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 14 Years 至 70 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •people diagnosed as AML
排除标准
- •acute promyeloytic leukemia
研究组 & 干预措施
high dose of cytarabine
high dose of cytarabine
干预措施: Flow Cytometer (Device)
high dose of cytarabine
high dose of cytarabine
干预措施: Mitoxantrone (Drug)
high dose of cytarabine
high dose of cytarabine
干预措施: Cytarabine (Drug)
HAM
medium dose of cytarabine and mitoxantrone
干预措施: Flow Cytometer (Device)
HAM
medium dose of cytarabine and mitoxantrone
干预措施: Mitoxantrone (Drug)
HAM
medium dose of cytarabine and mitoxantrone
干预措施: Cytarabine (Drug)
结局指标
主要结局
patient survival time
时间窗: three years
disease free survival
bone marrow suppression time
时间窗: one month
time of agranulocytosis
次要结局
未报告次要终点